Stock listing
BOATS:TVTX Travere Therapeutics, Inc. Stock
US listing (BOATS) of Travere Therapeutics, Inc. · home listing NASDAQ:TVTX
Follow Travere Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:TVTX
$49.60 USD +0.73 (+1.5%)
Close on Nov 6, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:TVTX
- Day range
- $48.64 – $50.45 USDNov 6, 2026
- Volume
- 992,432 sharesNov 6, 2026
- Market cap
- $4.68B USDAt the close on Nov 6, 2026 · price × 94.26M shares outstanding
- 52-week range
- $22.59 – $68.73 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $105.2M USDMedian day 1.56M shares · last 3 months, Aug 6, 2026 – Nov 6, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:TVTX · Home | $49.60 USD | +0.73 (+1.5%) | 992,432 | $49.74 | $50.45 | $48.64 | $48.87 | Close on Nov 6, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:TVTX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $49.60 | +0.73 | +1.5% | $49.74 | $50.45 | $48.64 | 992,432 | |
| $48.87 | -3.55 | -6.8% | $51.91 | $52.42 | $48.60 | 2,180,108 | |
| $52.42 | +3.01 | +6.1% | $50.27 | $53.30 | $49.16 | 3,570,517 | |
| $49.41 | +0.15 | +0.3% | $46.52 | $49.68 | $44.73 | 9,073,378 | |
| $49.26 | -1.13 | -2.2% | $50.47 | $52.87 | $48.64 | 2,879,342 | |
| $50.39 | -0.18 | -0.4% | $50.01 | $52.66 | $49.71 | 1,126,085 | |
| $50.57 | -0.275 | -0.5% | $51.65 | $52.15 | $49.90 | 1,562,435 | |
| $50.85 | -0.035 | -0.1% | $50.20 | $50.91 | $49.52 | 1,510,795 | |
| $50.88 | +0.91 | +1.8% | $49.85 | $50.99 | $49.29 | 3,307,818 | |
| $49.97 | -0.11 | -0.2% | $50.83 | $51.31 | $49.24 | 3,327,744 | |
| $50.08 | -2.35 | -4.5% | $52.00 | $52.22 | $49.78 | 2,314,500 | |
| $52.43 | -0.15 | -0.3% | $52.34 | $53.12 | $51.25 | 1,774,200 | |
| $52.58 | +0.28 | +0.5% | $52.88 | $54.83 | $52.50 | 2,164,200 | |
| $52.30 | +1.81 | +3.6% | $50.43 | $52.70 | $50.40 | 2,057,600 | |
| $50.49 | +0.89 | +1.8% | $50.17 | $51.28 | $49.74 | 1,315,500 | |
| $49.60 | -3.19 | -6.0% | $52.56 | $52.56 | $49.46 | 1,827,900 | |
| $52.79 | -0.48 | -0.9% | $53.94 | $55.57 | $52.63 | 1,980,600 | |
| $53.27 | +1.47 | +2.8% | $51.61 | $53.94 | $51.53 | 2,060,900 | |
| $51.80 | -0.22 | -0.4% | $51.57 | $52.81 | $51.38 | 1,668,600 | |
| $52.02 | -0.105 | -0.2% | $51.74 | $53.35 | $51.74 | 1,424,400 | |
| $52.13 | +0.085 | +0.2% | $52.04 | $52.71 | $51.63 | 1,169,400 | |
| $52.04 | -1.40 | -2.6% | $53.44 | $53.44 | $51.45 | 1,647,200 | |
| $53.44 | -2.54 | -4.5% | $55.41 | $56.61 | $53.28 | 3,424,000 | |
| $55.98 | -1.69 | -2.9% | $57.86 | $58.77 | $55.16 | 3,108,000 | |
| $57.67 | +0.74 | +1.3% | $57.31 | $58.60 | $55.86 | 2,643,900 | |
| $56.93 | +0.08 | +0.1% | $57.21 | $57.53 | $56.34 | 1,722,100 | |
| $56.85 | -2.03 | -3.4% | $58.64 | $59.58 | $56.23 | 2,394,400 | |
| $58.88 | -1.11 | -1.9% | $60.35 | $60.47 | $58.83 | 1,560,600 | |
| $59.99 | -1.58 | -2.6% | $61.04 | $61.87 | $59.33 | 1,565,100 | |
| $61.57 | +2.13 | +3.6% | $59.05 | $61.75 | $58.71 | 1,234,800 | |
| $59.44 | -1.18 | -1.9% | $60.89 | $60.89 | $59.05 | 1,205,900 | |
| $60.62 | +0.79 | +1.3% | $60.00 | $60.80 | $59.22 | 1,756,200 | |
| $59.83 | -0.45 | -0.7% | $60.39 | $60.89 | $58.32 | 1,713,800 | |
| $60.28 | -2.58 | -4.1% | $60.37 | $62.45 | $59.30 | 3,120,200 | |
| $62.86 | +0.10 | +0.2% | $63.01 | $63.64 | $61.85 | 1,583,800 | |
| $62.76 | -1.98 | -3.1% | $64.89 | $64.89 | $62.47 | 2,235,800 | |
| $64.74 | +1.26 | +2.0% | $64.51 | $65.86 | $63.84 | 1,384,700 | |
| $63.48 | +0.97 | +1.6% | $62.58 | $64.07 | $62.41 | 2,220,000 | |
| $62.51 | -3.28 | -5.0% | $65.31 | $65.32 | $61.40 | 2,097,800 | |
| $65.79 | -0.38 | -0.6% | $66.17 | $67.88 | $65.39 | 924,700 | |
| $66.17 | -1.34 | -2.0% | $67.76 | $68.73 | $66.11 | 1,149,800 | |
| $67.51 | +1.29 | +1.9% | $65.60 | $68.59 | $64.45 | 1,559,600 | |
| $66.22 | +0.15 | +0.2% | $65.80 | $68.23 | $65.59 | 1,235,800 | |
| $66.07 | +0.79 | +1.2% | $63.86 | $66.54 | $63.48 | 1,360,800 | |
| $65.28 | -1.26 | -1.9% | $66.04 | $67.11 | $65.04 | 1,050,500 | |
| $66.54 | -0.69 | -1.0% | $67.18 | $68.03 | $66.04 | 1,114,900 | |
| $67.23 | +1.52 | +2.3% | $66.37 | $67.82 | $65.76 | 1,085,700 | |
| $65.71 | -0.57 | -0.9% | $66.00 | $66.60 | $65.37 | 1,074,100 | |
| $66.28 | +0.61 | +0.9% | $65.70 | $66.70 | $65.07 | 1,891,200 | |
| $65.67 | -1.85 | -2.7% | $67.27 | $67.45 | $65.37 | 808,500 | |
| $67.52 | +0.40 | +0.6% | $66.69 | $67.85 | $65.65 | 911,600 | |
| $67.12 | +0.11 | +0.2% | $66.91 | $67.50 | $65.22 | 1,215,100 | |
| $67.01 | +1.79 | +2.7% | $65.74 | $67.34 | $65.74 | 1,507,400 | |
| $65.22 | -0.49 | -0.7% | $65.78 | $65.80 | $63.71 | 1,035,300 | |
| $65.71 | +1.25 | +1.9% | $64.78 | $66.38 | $64.50 | 1,624,900 | |
| $64.46 | -1.50 | -2.3% | $64.82 | $65.54 | $64.02 | 1,067,100 | |
| $65.96 | +2.06 | +3.2% | $65.00 | $66.19 | $63.34 | 1,522,000 | |
| $63.90 | +0.37 | +0.6% | $62.87 | $64.00 | $62.50 | 884,700 | |
| $63.53 | +1.39 | +2.2% | $62.15 | $64.38 | $61.62 | 1,565,500 | |
| $62.14 | +0.71 | +1.2% | $60.76 | $62.48 | $60.47 | 1,190,600 | |
| $61.43 | -0.73 | -1.2% | $63.33 | $63.33 | $61.06 | 1,285,300 | |
| $62.16 | +1.95 | +3.2% | $61.34 | $62.32 | $60.40 | 1,041,000 | |
| $60.21 | -0.68 | -1.1% | $60.75 | $61.97 | $60.20 | 1,282,700 | |
| $60.89 | -0.43 | -0.7% | $60.56 | $62.57 | $60.56 | 1,764,600 | |
| $61.32 | -1.13 | -1.8% | $63.53 | $63.71 | $60.67 | 1,226,400 | |
| $62.45 | -0.31 | -0.5% | $63.69 | $65.45 | $62.10 | 2,866,700 |
Splits
2 splits since 2009 · NASDAQ:TVTX · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-9 | Consolidation | |
| 1-for-100 | Consolidation |
- Ticker
- BOATS:TVTX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Nov 3, 2026
Travere Therapeutics to Participate at Upcoming Investor Conferences
Latest earnings call · Nov 2, 2026
Travere Therapeutics (NASDAQ:TVTX) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Aug 4, 2026
Q2 2026 Earnings Presentation
Earnings · 53 slides
Calls
Replays
Travere Therapeutics (NASDAQ:TVTX) Q3 2026 Earnings Call
Mon, Nov 02, 2026 · 4:30 PM ET
Watch TranscriptTravere Therapeutics (NASDAQ:TVTX) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 4:30 PM ET
Watch TranscriptTravere Therapeutics (NASDAQ:TVTX) Q1 2026 Earnings Call
Mon, May 04, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Travere Therapeutics to Participate at Upcoming Investor Conferences
Nov 3, 2026
Closed $52.42 (+6.1%) on Nov 4, 2026
Travere Therapeutics Reports Third Quarter 2026 Financial Results
Nov 2, 2026
Closed $49.41 (+0.3%) on Nov 3, 2026
Travere Therapeutics to Report Third Quarter 2026 Financial Results
Oct 26, 2026
Closed $50.88 (+1.8%) on Oct 27, 2026
Travere Presents New Biomarker Data at ASN Kidney Week Suggesting FILSPARI® (sparsentan) May Modify Underlying Disease Pathophysiology in IgA Nephropathy
Oct 23, 2026
Closed $49.97 (-0.2%) on Oct 26, 2026
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 12, 2026
Closed $51.80 (-0.4%) on Oct 13, 2026
Travere to Present New Data Supporting FILSPARI® (sparsentan) as Foundational Treatment in IgA Nephropathy and FSGS at ASN Kidney Week 2026
Oct 2, 2026
Closed $56.93 (+0.1%) on Oct 2, 2026
Travere Therapeutics Receives Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Directed to Certain Methods of Using FILSPARI® (sparsentan) in Focal Segmental Glomerulosclerosis
Sep 23, 2026
Closed $59.83 (-0.7%) on Sep 23, 2026
Travere Therapeutics Announces Planned Chief Executive Officer Transition
Sep 21, 2026
Closed $60.28 (-4.1%) on Sep 22, 2026
Travere Therapeutics to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum
Sep 17, 2026
Closed $62.76 (-3.1%) on Sep 18, 2026
Travere Therapeutics Reports Second Quarter 2026 Financial Results
Aug 4, 2026
Closed $62.76 (+12.0%) on Aug 5, 2026
Financings
Convertible senior notes due 2032
May 5, 2026
Announced: US$400M · J.P. Morgan +2
Dealers: J.P. Morgan (co-lead), Jefferies (co-lead), Leerink Partners (co-lead)
Use of proceeds: Repurchase part of outstanding 2.25% convertible notes due 2029; remainder for general corporate purposes incl. commercialization and R&D
Public offering of common stock
Nov 12, 2024
Closed: US$143.8M raised · US$16 a share · Jefferies +2
Dealers: Jefferies (co-lead), Leerink Partners (co-lead), Wedbush PacGrow
Decks
Q2 2026 Earnings Presentation
Earnings · 53 slides · Aug 4, 2026
Corporate Update (June 2026)
Corporate update · 19 slides · Jun 2, 2026
Q1 2026 Earnings Presentation
Earnings · 48 slides · May 4, 2026
Corporate Update (April 2026)
Corporate update · 25 slides · Apr 13, 2026
Travere Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 26 in the last 12 months · 171 in all · newest Nov 3, 2026 · oldest 2020
- Calls
- 24 calls with a replay · 24 with a transcript · latest Nov 2, 2026
- Decks
- 18 decks · latest Aug 4, 2026
Where Travere Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TVTX · Home listing | NASDAQ | United States | USD |
| BOATS:TVTX · This page | BOATS | United States | USD |
| Tradegate:17R | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Travere Therapeutics, Inc.